Showing results (361-370 of 383) with videos related to

Sort By:
Pageof 39
American Heart Journal|June 5, 2017
Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularizationAnthony J Dalby, Shmuel Gottlieb, Derek D Cyr, et al.
Scientific Reports|November 19, 2020
JavaCyte, a novel open-source tool for automated quantification of key hallmarks of cardiac structural remodelingJ Winters, M Edler von Braunmuhl, S Zeemering, et al.
Clinical Chemistry|May 19, 2017
Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary SyndromeMark Y Chan, Megan L Neely, Matthew T Roe, et al.
Journal of Hematology & Oncology|February 19, 2013
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell diseaseTed Wun, Denis Soulieres, Andrew L Frelinger, et al.
Journal of the American College of Cardiology|June 11, 2013
Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patientsDavid Erlinge, Paul A Gurbel, Stefan James, et al.
Journal of the American Medical Informatics Association : JAMIA|November 23, 2012
Online disease management of diabetes: engaging and motivating patients online with enhanced resources-diabetes (EMPOWER-D), a randomized controlled trialPaul C Tang, J Marc Overhage, Albert Solomon Chan, et al.
Heart (British Cardiac Society)|April 1, 2016
Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patientsChee Tang Chin, William E Boden, Matthew T Roe, et al.
Plos Biology|October 21, 2022
Comprehensive characterization of the Hsp70 interactome reveals novel client proteins and interactions mediated by posttranslational modificationsNitika, Bo Zheng, Linhao Ruan, et al.
Clinical Cardiology|July 29, 2016
Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS TrialLarry R Jackson, Jonathan P Piccini, Derek D Cyr, et al.
American Heart Journal|September 21, 2015
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trialJose Carlos Nicolau, Deepak L Bhatt, Matthew T Roe, et al.
Pageof 39